Moleculin Biotech, Inc. (MBRX)

Moleculin Biotech Statistics

Total Valuation

MBRX has a market cap or net worth of $13.29 million. The enterprise value is $4.77 million.

Market Cap	13.29M
Enterprise Value	4.77M

Important Dates

The last earnings date was Thursday, March 19, 2026, before market open.

Earnings Date	Mar 19, 2026
Ex-Dividend Date	n/a

Share Statistics

MBRX has 5.34 million shares outstanding. The number of shares has increased by 760.13% in one year.

Current Share Class	5.34M
Shares Outstanding	5.34M
Shares Change (YoY)	+760.13%
Shares Change (QoQ)	+50.05%
Owned by Insiders (%)	0.83%
Owned by Institutions (%)	2.97%
Float	5.29M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.53
P/TBV Ratio	3.44
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.41, with a Debt / Equity ratio of 0.02.

Current Ratio	1.41
Quick Ratio	1.30
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -256.05% and return on invested capital (ROIC) is -116.00%.

Return on Equity (ROE)	-256.05%
Return on Assets (ROA)	-80.35%
Return on Invested Capital (ROIC)	-116.00%
Return on Capital Employed (ROCE)	-164.37%
Weighted Average Cost of Capital (WACC)	13.44%
Revenue Per Employee	n/a
Profits Per Employee	-$1.98M
Employee Count	17
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -90.60% in the last 52 weeks. The beta is 1.74, so MBRX's price volatility has been higher than the market average.

Beta (5Y)	1.74
52-Week Price Change	-90.60%
50-Day Moving Average	3.29
200-Day Moving Average	9.18
Relative Strength Index (RSI)	48.33
Average Volume (20 Days)	131,020

Short Selling Information

The latest short interest is 191,156, so 3.58% of the outstanding shares have been sold short.

Short Interest	191,156
Short Previous Month	441,371
Short % of Shares Out	3.58%
Short % of Float	3.61%
Short Ratio (days to cover)	2.16

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-25.10M
Pretax Income	-33.56M
Net Income	-33.66M
EBITDA	-25.01M
EBIT	-25.10M
Earnings Per Share (EPS)	-$28.42

Balance Sheet

The company has $8.88 million in cash and $359,000 in debt, with a net cash position of $8.52 million or $1.60 per share.

Cash & Cash Equivalents	8.88M
Total Debt	359,000
Net Cash	8.52M
Net Cash Per Share	$1.60
Equity (Book Value)	15.01M
Book Value Per Share	4.69
Working Capital	2.83M

Cash Flow

Operating Cash Flow	-22.74M
Capital Expenditures	n/a
Depreciation & Amortization	90,000
Net Borrowing	n/a
Free Cash Flow	-22.74M
FCF Per Share	-$4.26

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MBRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-760.13%
Shareholder Yield	-760.13%
Earnings Yield	-253.35%
FCF Yield	-171.10%

Analyst Forecast

The average price target for MBRX is $105.50, which is 4,136.95% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$105.50
Price Target Difference	4,136.95%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on December 1, 2025. It was a reverse split with a ratio of 1:25.

Last Split Date	Dec 1, 2025
Split Type	Reverse
Split Ratio	1:25

Scores

Altman Z-Score	n/a
Piotroski F-Score	2